Castle Biosciences

Castle Biosciences is a commercial-stage dermatological cancer company dedicated to providing personalized, clinically actionable genomic information to doctors and their patients to make more accurate treatment decisions. Castle Biosciences develops and commercializes diagnostic and prognostic tests for dermatological conditions. The company's tests provide clinically actionable tumor-specific genomic information to enable more accurate treatment planning decisions. Castle Biosciences believes that the traditional approach of formulating dermatological treatment plans using only clinical and pathological factors is insufficient and can be improved by incorporating personalized genomic information.